Sjögren’s Syndrome News

Patients with pulmonary arterial hypertension associated with connective tissue disease demonstrate a “poor” 10-year rate of 59.9%, according to data published in Rheumatology.

The presence of anti-SSA/RO antibodies in pregnant patients can predict adverse pregnancy outcomes, including spontaneous abortion, according to data published in Pediatric Rheumatology.

A novel, fully automated multiparametric autoantibody analysis may improve the early diagnosis of connective tissue diseases, particularly lupus and Sjögren’s syndrome, according to data published in Arthritis Research & Therapy.

Dazodalibep has successfully improved disease activity and symptoms two patient populations with Sjögren’s syndrome in a phase 2 trial, according to a press release from Horizon Therapeutics.

In this episode, Dr. Benjamin Claytor walks us through his approach to suspected sensory ganglionopathies. I also cover other neurologic complications of Sjogren’s syndrome and some interesting history on vitamin B6.

A sensational (or lack thereof) series on the signs and symptoms of the spellbinding sensory ganglionopathies.

PHILADELPHIA — Results of a phase 2 proof-of-concept study showed that an oral Bruton’s tyrosine kinase inhibitor demonstrates trends toward efficacy in Sjögren's syndrome, according to data presented at ACR Convergence 2022.

Sept. 14 marks the second annual ILD Day, which aims to increase awareness of interstitial lung diseases.

Although they exhibit a greater risk for severe immune-related adverse effects, patients with preexisting autoimmune disease receiving immune checkpoint inhibitors for melanoma had better 2-year survival than controls, according to data.

Exposure to fine particulate matter — specifically particles 2.5 µm or less in diameter, or PM2.5 — in the air signals a higher risk for systemic autoimmune rheumatic diseases, according to data published in Arthritis Research & Therapy.